Home/Filings/4/0001437749-20-004438
4//SEC Filing

Mickle Travis C 4

Accession 0001437749-20-004438

CIK 0001434647other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:18 PM ET

Size

17.1 KB

Accession

0001437749-20-004438

Insider Transaction Report

Form 4
Period: 2020-03-05
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+3,000$1,0021,759,117 total
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+4,500$1,4991,763,617 total
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+4,500$1,5021,768,117 total
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+3,000$9901,771,117 total
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+2,500$8251,778,117 total
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+3,000$1,0031,756,117 total
  • Purchase

    Common Stock

    2020-03-05$0.33/sh+4,500$1,4841,775,617 total
Holdings
  • Common Stock

    (indirect: By Trust)
    157,197
  • Common Stock

    (indirect: By Trust)
    123,217
  • Common Stock

    100,604
  • Common Stock

    (indirect: By Trust)
    243,880
  • Common Stock

    (indirect: By Trust)
    21,466
  • Common Stock

    (indirect: By LLC)
    16,550
Footnotes (2)
  • [F1]Held jointly with Christal M.M. Mickle.
  • [F2]The Reporting Person and Christal M.M. Mickle are the managing members of Mickle Investments, LLC.

Issuer

KEMPHARM, INC

CIK 0001434647

Entity typeother

Related Parties

1
  • filerCIK 0001638365

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:18 PM ET
Size
17.1 KB